Clinical efficacy of casirivimab and imdevimab in preventing COVID-19 in the Omicron BA.5 subvariant epidemic: a retrospective study.
Saved in:
| Title: | Clinical efficacy of casirivimab and imdevimab in preventing COVID-19 in the Omicron BA.5 subvariant epidemic: a retrospective study. |
|---|---|
| Authors: | Ohtani M; Department of Pharmacy, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan. mariko.ootani@med.toho-u.ac.jp.; Department of Infection Control and Prevention, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan. mariko.ootani@med.toho-u.ac.jp., Yokoo T; Department of Pharmacy, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan., Miyazaki T; Department of Infection Control and Prevention, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.; General Medicine and Emergency Center, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan., Yasuda H; Department of Pharmacy, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan., Nishikawa E; Department of Infection Control and Prevention, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan., Tomida M; Department of Infection Control and Prevention, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan., Tsukada M; Department of Infection Control and Prevention, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan., Sato E; Department of Nursing, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan., Hirayama S; Department of Pharmacy, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan., Murakami H; Department of Infection Control and Prevention, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.; Department of Clinical Laboratory, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan., Yoshizawa S; Department of Clinical Laboratory, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.; Department of Microbiology and Infectious Diseases, Toho University School of Medicine, 5-21-16 Omori-Nishi, Ota-Ku, Tokyo, 143-8540, Japan., Matsumoto T; Department of Pharmacy, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan., Tateda K; Department of Infection Control and Prevention, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.; Department of Clinical Laboratory, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.; Department of Microbiology and Infectious Diseases, Toho University School of Medicine, 5-21-16 Omori-Nishi, Ota-Ku, Tokyo, 143-8540, Japan. |
| Source: | Journal of pharmaceutical health care and sciences [J Pharm Health Care Sci] 2025 Oct 27; Vol. 11 (1), pp. 94. Date of Electronic Publication: 2025 Oct 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101672177 Publication Model: Electronic Cited Medium: Print ISSN: 2055-0294 (Print) Linking ISSN: 20550294 NLM ISO Abbreviation: J Pharm Health Care Sci Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41146359 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical efficacy of casirivimab and imdevimab in preventing COVID-19 in the Omicron BA.5 subvariant epidemic: a retrospective study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ohtani+M%22">Ohtani M</searchLink>; Department of Pharmacy, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan. mariko.ootani@med.toho-u.ac.jp.; Department of Infection Control and Prevention, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan. mariko.ootani@med.toho-u.ac.jp.<br /><searchLink fieldCode="AU" term="%22Yokoo+T%22">Yokoo T</searchLink>; Department of Pharmacy, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.<br /><searchLink fieldCode="AU" term="%22Miyazaki+T%22">Miyazaki T</searchLink>; Department of Infection Control and Prevention, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.; General Medicine and Emergency Center, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.<br /><searchLink fieldCode="AU" term="%22Yasuda+H%22">Yasuda H</searchLink>; Department of Pharmacy, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.<br /><searchLink fieldCode="AU" term="%22Nishikawa+E%22">Nishikawa E</searchLink>; Department of Infection Control and Prevention, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.<br /><searchLink fieldCode="AU" term="%22Tomida+M%22">Tomida M</searchLink>; Department of Infection Control and Prevention, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.<br /><searchLink fieldCode="AU" term="%22Tsukada+M%22">Tsukada M</searchLink>; Department of Infection Control and Prevention, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.<br /><searchLink fieldCode="AU" term="%22Sato+E%22">Sato E</searchLink>; Department of Nursing, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.<br /><searchLink fieldCode="AU" term="%22Hirayama+S%22">Hirayama S</searchLink>; Department of Pharmacy, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.<br /><searchLink fieldCode="AU" term="%22Murakami+H%22">Murakami H</searchLink>; Department of Infection Control and Prevention, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.; Department of Clinical Laboratory, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshizawa+S%22">Yoshizawa S</searchLink>; Department of Clinical Laboratory, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.; Department of Microbiology and Infectious Diseases, Toho University School of Medicine, 5-21-16 Omori-Nishi, Ota-Ku, Tokyo, 143-8540, Japan.<br /><searchLink fieldCode="AU" term="%22Matsumoto+T%22">Matsumoto T</searchLink>; Department of Pharmacy, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.<br /><searchLink fieldCode="AU" term="%22Tateda+K%22">Tateda K</searchLink>; Department of Infection Control and Prevention, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.; Department of Clinical Laboratory, Toho University Omori Medical Center, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.; Department of Microbiology and Infectious Diseases, Toho University School of Medicine, 5-21-16 Omori-Nishi, Ota-Ku, Tokyo, 143-8540, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101672177%22">Journal of pharmaceutical health care and sciences</searchLink> [J Pharm Health Care Sci] 2025 Oct 27; Vol. 11 (1), pp. 94. <i>Date of Electronic Publication: </i>2025 Oct 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101672177 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2055-0294 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220550294%22">20550294 </searchLink><i>NLM ISO Abbreviation: </i>J Pharm Health Care Sci <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41146359 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s40780-025-00501-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 94 Titles: – TitleFull: Clinical efficacy of casirivimab and imdevimab in preventing COVID-19 in the Omicron BA.5 subvariant epidemic: a retrospective study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ohtani M – PersonEntity: Name: NameFull: Yokoo T – PersonEntity: Name: NameFull: Miyazaki T – PersonEntity: Name: NameFull: Yasuda H – PersonEntity: Name: NameFull: Nishikawa E – PersonEntity: Name: NameFull: Tomida M – PersonEntity: Name: NameFull: Tsukada M – PersonEntity: Name: NameFull: Sato E – PersonEntity: Name: NameFull: Hirayama S – PersonEntity: Name: NameFull: Murakami H – PersonEntity: Name: NameFull: Yoshizawa S – PersonEntity: Name: NameFull: Matsumoto T – PersonEntity: Name: NameFull: Tateda K IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 10 Text: 2025 Oct 27 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2055-0294 Numbering: – Type: volume Value: 11 – Type: issue Value: 1 Titles: – TitleFull: Journal of pharmaceutical health care and sciences Type: main |
| ResultId | 1 |